Abstract | BACKGROUND: The use of ventricular assist devices (VAD) has become a widely accepted therapeutic option. However, there are still limitations to the patient collective eligible for VAD placement, who might therefore benefit from the implantation of a total artificial heart. We present the first German single-center experience with the CardioWest total artificial heart (TAH) (SynCardia Systems, Tucson, AZ) in 42 patients. METHODS: RESULTS: Duration of support was 1 to 291 days. Eleven patients (26%) underwent successful transplantation; 9 of them could be discharged home. Twenty-two patients died under support, 21 of them from multiple organ failure and 1 patient from a technical problem. Nine patients are still on the device, 4 of them at home after the original CardioWest console was replaced by the Berlin Heart EXCOR driver (Berlin Heart, Berlin, Germany). Exceptional results were achieved in patients with cardiogenic shock after cardiac surgery or after acute myocardial infarction. CONCLUSIONS: Against the background of the extremely poor preoperative situation of our patients, the overall survival rate of 48% can be considered as favorable. A prospective, randomized study is planned to find out whether patients with idiopathic dilated or ischemic cardiomyopathy are more likely to benefit from a biventricular assist device or a total artificial heart.
|
Authors | Aly El-Banayosy, Latif Arusoglu, Michel Morshuis, Lukasz Kizner, Gero Tenderich, Peter Sarnowski, Hendrik Milting, Reiner Koerfer |
Journal | The Annals of thoracic surgery
(Ann Thorac Surg)
Vol. 80
Issue 2
Pg. 548-52
(Aug 2005)
ISSN: 1552-6259 [Electronic] Netherlands |
PMID | 16039202
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Topics |
- Adult
- Cardiac Surgical Procedures
- Female
- Heart, Artificial
- Humans
- Male
- Middle Aged
- Shock, Cardiogenic
(surgery)
|